搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Future Market Insights
3 天
Global Low-Grade Glioma Therapeutics Market Poised for Robust Growth, Reaching USD 1515.47 ...
The global low-grade glioma therapeutics market is set to experience significant growth, according to a new comprehensive ...
Onlymyhealth
3 天
Nepali Influencer Bibek Pangeni Loses His Life To Third-Stage Glioma: Symptoms and ...
Bibek Pangeni one half of the famous Nepali influencer couple lost his life due to a third-stage glioma Here is what you need ...
2 天
on MSN
Social Media Influencer Bibek Pangeni Dies of Brain Cancer; Know All About Fourth-stage ...
Internet sensation Bibek Pangeni passed away after a long battle with a malignant brain tumour known as glioma, which forms ...
2 天
Bibek Pangeni Passes Away After Brave Battle with Glioma; Srijana Subedi Receives Praise ...
Bibek Pangeni, a Nepali social media figure, dies after battling glioma. His wife, Srijana Subedi, receives praise for her ...
6 天
on MSN
TikToker Joules Dies After Rare Brain Tumor at 6 Years Old. Her Death Inspires Phenomenon ...
Joules Smith's Father Joe confirmed on social media that the six-year-old died on Dec. 9 six months after she was diagnosed ...
Physics World
4 天
AI-powered tool detects residual tumour during brain surgery
The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...
3 天
Nepali Influencer Bibek Pangeni Loses His Life To Third-Stage Glioma, Last Video goes Viral
Nepali influencer couple, Bibek Pangeni and Srijana Subedi have been in the headlines for the treatment of the husband who ...
3 天
on MSN
Nepali influencer Bibek Pangeni passes away after cancer battle
Bibek Pangeni, a Nepali social media personality and a PhD candidate in Physics and Astronomy at the University of Georgia, ...
11 天
Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy
Chimerix’s dordaviprone shows potential for glioma treatment with a possible FDA approval by 2025. Read why CMRX stock is a ...
13 天
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with ...
Potential Approval in Q3 2025 in Recurrent H3 K27M-Mutant Diffuse GliomaSubmission Plan Follows Productive and Collaborative Pre-NDA Interactions ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈